1. Home
  2. LIVE vs ALXO Comparison

LIVE vs ALXO Comparison

Compare LIVE & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

HOLD

Current Price

$15.20

Market Cap

30.3M

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.52

Market Cap

79.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
ALXO
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
79.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LIVE
ALXO
Price
$15.20
$1.52
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$3.30
AVG Volume (30 Days)
9.5K
268.8K
Earning Date
12-11-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.93
N/A
Revenue
$444,944,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$0.40
52 Week High
$25.88
$2.27

Technical Indicators

Market Signals
Indicator
LIVE
ALXO
Relative Strength Index (RSI) 69.30 54.56
Support Level $9.05 $1.29
Resistance Level $12.49 $1.57
Average True Range (ATR) 1.43 0.12
MACD 0.73 0.02
Stochastic Oscillator 74.22 80.00

Price Performance

Historical Comparison
LIVE
ALXO

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: